Research article

A novel model-based approach for dose determination of glycopyrronium bromide in COPD

Helen Arievich¹, Tim Overend²^*, Didier Renard³, Michael Gibbs², Vijay Alagappan², Michael Looby³ and Donald Banerji⁴

¹ Medars GmbH, Berlin, Germany

² Novartis Horsham Research Centre, Wimblehurst Road, Horsham, West Sussex, RH12 5AB, UK

³ Novartis Pharma AG, Basel, Switzerland

⁴ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

For all author emails, please log on.

BMC Pulmonary Medicine 2012, 12:74 doi:10.1186/1471-2466-12-74

Published: 8 December 2012

Additional file 1:

Appendix 1. Study centers and ethics committee.

Format: DOC Size: 44KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional file 2:

Appendix 2. Analysis methodology.

Format: DOC Size: 83KB Download file

This file can be viewed with: Microsoft Word Viewer